ROBERTS EIRY Insider Trades

Insider Trading History

Track insider trading activity for ROBERTS EIRY. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bausch Health Companies
Bausch Health Companies BHC
Director
Holding Value $227k 45,871 shares
Last Trade
May 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$251k 45,871 shares
$5.47
$4.95
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$442k 30,474 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$615k 42,467 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.11M 76,275 shares
$14.50
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.08M 74,872 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$589k 40,625 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$658k 45,423 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $1.11M 76,275 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$446k 74,872 shares
$5.96
$14.49
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $5.88M 35,640 shares
Last Trade
Feb 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$57.5k 500 shares
$115.04
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $5.74M 34,768 shares
Last Trade
Feb 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$201k 1,718 shares
$116.84
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $7.14M 43,261 shares
Last Trade
Feb 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.07M 43,261 shares
$117.18
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $5.49M 33,253 shares
Last Trade
Feb 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$116k 980 shares
$118.22
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Feb 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$228k 1,860 shares
$122.62
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $5.65M 34,233 shares
Last Trade
Feb 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$228k 1,860 shares
$122.62
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $5.59M 33,830 shares
Last Trade
Jan 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$420k 2,769 shares
$151.82
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $457k 2,769 shares
Last Trade
Jan 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$420k 2,769 shares
$151.82
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $5.35M 32,373 shares
Last Trade
Jan 31, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$223k 1,457 shares
$152.80
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $4.59M 27,770 shares
Last Trade
Dec 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.8M 27,770 shares
$136.69
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $209k 1,265 shares
Last Trade
Nov 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$924k 7,345 shares
$125.74
$165.11
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Medical Officer
Holding Value $5.13M 31,061 shares
Last Trade
Nov 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$924k 7,345 shares
$125.74
$165.11

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up